Liposomes to Augment Dialysis in Preclinical Models; A Structured Review

In recent years, a number of groups have been investigating the use of “empty” liposomes with no drug loaded as scavengers both for exogenous intoxicants and endogenous toxic molecules. Preclinical trials have demonstrated that repurposing liposomes to sequester such compounds may prove clinically u...

Full description

Bibliographic Details
Main Authors: Kevin Hart, Martyn Harvey, Mingtan Tang, Zimei Wu, Grant Cave
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/3/395

Similar Items